Extended Data Fig. 4: Subcluster analysis of T/NK lymphocyte populations.
From: Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
a, UMAP of T/NK cells colored according to immune cell types. b, UMAP plots showing normalized expressions of marker genes used for subclustering of T/NK cells. c, UMAP plots of proliferating lymphocytes colored according to immune cell types. d, Dot plots showing the average normalized expressions of marker genes used for subclustering of proliferating lymphocytes. e, Dot plots showing the average normalized expression of marker genes in CD8+ T-cell subclusters.
